Novel treatments for novel side effects: a case report and review of baricitinib use in the treatment of chronic inflammatory demyelinating polyneuropathy caused by immune checkpoint inhibitor use
Sana Haider(Camden and Campbelltown Hospitals), Karuna Keat(Camden and Campbelltown Hospitals), Stephen Della‐Fiorentina(Camden and Campbelltown Hospitals), Bavanthi Balakrishnar(Liverpool Hospital), Tara L. Roberts(Camden and Campbelltown Hospitals), Wei Chua(Liverpool Hospital)
Cited by 3
Related Papers
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
|Science|2009|822
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507
The mammalian PYHIN gene family: Phylogeny, evolution and expression
|BMC Evolutionary Biology|2012|202
The Molecular Basis for the Lack of Immunostimulatory Activity of Vertebrate DNA
|The Journal of Immunology|2003|174
Cutting Edge: Species-Specific TLR9-Mediated Recognition of CpG and Non-CpG Phosphorothioate-Modified Oligonucleotides
|The Journal of Immunology|2005|133